StockData

China SXT Pharmaceuticals, Inc. (SXTC) stock

SXTCNasdaqPharmaceutical PreparationsFiscal year ends March 31
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jul 1, 2026Score 4/30
$2.86−0.13 (-4.35%)

Close on Nov 17, 2026Market cap $2.74MP/E –Yield –

China SXT Pharmaceuticals operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2026 it was -$4.02M. The highest annual figure on record is $1.92M in fiscal 2018.

Annual operating cash flow

PeriodPeriod endValueChange
FY2026Mar 31, 2026-$4.02M–
FY2025Mar 31, 2025-$2.35M–
FY2024Mar 31, 2024-$1.93M–
FY2023Mar 31, 2023-$80.76K-130.1%
FY2022Mar 31, 2022$268.29K–
FY2021Mar 31, 2021-$1.32M-240.9%
FY2020Mar 31, 2020$934.25K+290.6%
FY2019Mar 31, 2019$239.19K-87.5%
FY2018Mar 31, 2018$1.92M+555.3%
FY2017Mar 31, 2017$293.04K–

More China SXT Pharmaceuticals figures

See a number that looks wrong?